Aspirin is a NSAIDs that inhibit the synthesis of cyclooxygenase. The arachidonic will still synthesis Cyclo-oxygenase which leads to an increase in the synthesis leukotrienes.LT are potent vasoconstrictors that cause bronchospasm. Bronchospasm is contraindicated in patients with asthma.
Arachidonic acid needs to be released from membrane phospholipids in order to start the Eicosanoid process. AA is released by three different phospholipase classes.
First is Cytosolic PLA2 (phospholipase A2)
Secretory PLA2 (Calcium dependant)
Calcium independent PLA2 (Where chemical and physical stimuli activate the calcium translocation of PLA2 to plasma membrane, this then allows the release of Arachidonic acid and so the start of the Eicosanoid synthesis.
Leukotrienes and Thromboxane.
Cyclo-oxygenase plays a direct part in the inflammation process specifically as it synthesises PGI2, TXA and PG.
A drug that inhibits each of the following enzymes:
phospholipase A; Hydrocortisone, Dexamethasone, Prednisolone.
cyclooxygenase; Aspirin, ibuprofen
lipoxygenase, Zileuton
A drug that can act antagonistically or agonistically at prostaglandin and leukotriene receptors.
Montelukast, Zafirlukast
Thromboxane promotes platelet synthesis whereas prostacyclin inhibits platelet aggregation. As soon as a Cyclo-oxygenase inhibitor is used no platelet aggregation will occur.
Alprostadil is PGE1, which induces vasodilation and inhibits platelet aggregation.
Misoprostol is a PGE1 eicosanoid that helps protect the gastric mucosa preventing the formation of sores within the stomach lining i.e., gastric ulcers.
PGE2 would be of better value because PGF2 is a potent bronchoconstrictor.
Latanoprost increase the outflow of aqueous humor.